nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—ABCB1—colon cancer	0.373	1	CbGaD
Captopril—ALB—Irinotecan—colon cancer	0.0477	0.229	CbGbCtD
Captopril—ALB—Fluorouracil—colon cancer	0.0458	0.22	CbGbCtD
Captopril—SLC22A6—Methotrexate—colon cancer	0.0296	0.142	CbGbCtD
Captopril—ALB—Methotrexate—colon cancer	0.0252	0.121	CbGbCtD
Captopril—ABCB1—Irinotecan—colon cancer	0.025	0.12	CbGbCtD
Captopril—ABCB1—Vincristine—colon cancer	0.0218	0.105	CbGbCtD
Captopril—F2—hepatic artery—colon cancer	0.0181	0.103	CbGeAlD
Captopril—F2—portal vein—colon cancer	0.0157	0.0894	CbGeAlD
Captopril—ABCB1—Methotrexate—colon cancer	0.0132	0.0634	CbGbCtD
Captopril—REN—vein—colon cancer	0.0129	0.0737	CbGeAlD
Captopril—F2—vein—colon cancer	0.00903	0.0514	CbGeAlD
Captopril—ACE—vein—colon cancer	0.00552	0.0314	CbGeAlD
Captopril—REN—blood vessel—colon cancer	0.00411	0.0234	CbGeAlD
Captopril—MMP2—endothelium—colon cancer	0.0041	0.0233	CbGeAlD
Captopril—ACE—umbilical vein—colon cancer	0.00401	0.0228	CbGeAlD
Captopril—MMP2—blood vessel—colon cancer	0.00378	0.0215	CbGeAlD
Captopril—MMP9—endothelium—colon cancer	0.00356	0.0203	CbGeAlD
Captopril—MMP2—gall bladder—colon cancer	0.00355	0.0202	CbGeAlD
Captopril—MMP9—blood vessel—colon cancer	0.00328	0.0187	CbGeAlD
Captopril—LTA4H—embryo—colon cancer	0.00318	0.0181	CbGeAlD
Captopril—F2—endothelium—colon cancer	0.00311	0.0177	CbGeAlD
Captopril—F2—blood vessel—colon cancer	0.00287	0.0163	CbGeAlD
Captopril—F2—gall bladder—colon cancer	0.0027	0.0154	CbGeAlD
Captopril—LTA4H—smooth muscle tissue—colon cancer	0.0025	0.0142	CbGeAlD
Captopril—LTA4H—renal system—colon cancer	0.0024	0.0137	CbGeAlD
Captopril—MMP2—embryo—colon cancer	0.00225	0.0128	CbGeAlD
Captopril—REN—epithelium—colon cancer	0.002	0.0114	CbGeAlD
Captopril—LTA4H—lymphoid tissue—colon cancer	0.002	0.0114	CbGeAlD
Captopril—LTA4H—digestive system—colon cancer	0.00197	0.0112	CbGeAlD
Captopril—MMP9—embryo—colon cancer	0.00196	0.0112	CbGeAlD
Captopril—REN—smooth muscle tissue—colon cancer	0.00193	0.011	CbGeAlD
Captopril—ACE—endothelium—colon cancer	0.0019	0.0108	CbGeAlD
Captopril—REN—renal system—colon cancer	0.00186	0.0106	CbGeAlD
Captopril—MMP2—epithelium—colon cancer	0.00184	0.0105	CbGeAlD
Captopril—LTA4H—bone marrow—colon cancer	0.00182	0.0103	CbGeAlD
Captopril—MMP2—smooth muscle tissue—colon cancer	0.00177	0.0101	CbGeAlD
Captopril—ACE—blood vessel—colon cancer	0.00175	0.00997	CbGeAlD
Captopril—LTA4H—vagina—colon cancer	0.00174	0.00991	CbGeAlD
Captopril—ALB—gall bladder—colon cancer	0.00172	0.0098	CbGeAlD
Captopril—MMP2—renal system—colon cancer	0.00171	0.00971	CbGeAlD
Captopril—MMP9—epithelium—colon cancer	0.0016	0.0091	CbGeAlD
Captopril—MMP9—smooth muscle tissue—colon cancer	0.00154	0.00877	CbGeAlD
Captopril—REN—digestive system—colon cancer	0.00152	0.00866	CbGeAlD
Captopril—MMP9—renal system—colon cancer	0.00148	0.00844	CbGeAlD
Captopril—LTA4H—liver—colon cancer	0.00147	0.00836	CbGeAlD
Captopril—MMP2—lymphoid tissue—colon cancer	0.00142	0.00806	CbGeAlD
Captopril—MMP2—digestive system—colon cancer	0.0014	0.00796	CbGeAlD
Captopril—F2—epithelium—colon cancer	0.0014	0.00794	CbGeAlD
Captopril—F2—renal system—colon cancer	0.00129	0.00737	CbGeAlD
Captopril—MMP2—vagina—colon cancer	0.00124	0.00703	CbGeAlD
Captopril—MMP9—lymphoid tissue—colon cancer	0.00123	0.00701	CbGeAlD
Captopril—MMP9—digestive system—colon cancer	0.00122	0.00693	CbGeAlD
Captopril—SLC15A1—epithelium—colon cancer	0.00119	0.00677	CbGeAlD
Captopril—REN—liver—colon cancer	0.00113	0.00645	CbGeAlD
Captopril—LTA4H—lymph node—colon cancer	0.00113	0.00641	CbGeAlD
Captopril—MMP9—bone marrow—colon cancer	0.00112	0.00638	CbGeAlD
Captopril—SLC15A1—renal system—colon cancer	0.0011	0.00628	CbGeAlD
Captopril—F2—lymphoid tissue—colon cancer	0.00107	0.00612	CbGeAlD
Captopril—F2—digestive system—colon cancer	0.00106	0.00604	CbGeAlD
Captopril—ACE—embryo—colon cancer	0.00104	0.00595	CbGeAlD
Captopril—MMP2—liver—colon cancer	0.00104	0.00593	CbGeAlD
Captopril—F2—bone marrow—colon cancer	0.000978	0.00557	CbGeAlD
Captopril—MMP9—liver—colon cancer	0.000906	0.00516	CbGeAlD
Captopril—SLC15A1—digestive system—colon cancer	0.000904	0.00515	CbGeAlD
Captopril—ACE—epithelium—colon cancer	0.000852	0.00485	CbGeAlD
Captopril—ACE—smooth muscle tissue—colon cancer	0.000821	0.00468	CbGeAlD
Captopril—MMP2—lymph node—colon cancer	0.000799	0.00455	CbGeAlD
Captopril—SLC15A1—vagina—colon cancer	0.000799	0.00455	CbGeAlD
Captopril—F2—liver—colon cancer	0.000791	0.0045	CbGeAlD
Captopril—ACE—renal system—colon cancer	0.000791	0.0045	CbGeAlD
Captopril—MMP9—lymph node—colon cancer	0.000695	0.00396	CbGeAlD
Captopril—SLC15A1—liver—colon cancer	0.000674	0.00384	CbGeAlD
Captopril—ACE—lymphoid tissue—colon cancer	0.000656	0.00374	CbGeAlD
Captopril—ACE—digestive system—colon cancer	0.000648	0.00369	CbGeAlD
Captopril—ABCB1—blood vessel—colon cancer	0.000616	0.00351	CbGeAlD
Captopril—ACE—bone marrow—colon cancer	0.000598	0.0034	CbGeAlD
Captopril—Muscular weakness—Fluorouracil—colon cancer	0.000592	0.00428	CcSEcCtD
Captopril—Pancytopenia—Vincristine—colon cancer	0.00059	0.00427	CcSEcCtD
Captopril—Angina pectoris—Irinotecan—colon cancer	0.00059	0.00426	CcSEcCtD
Captopril—Urine output increased—Capecitabine—colon cancer	0.000584	0.00422	CcSEcCtD
Captopril—Neutropenia—Vincristine—colon cancer	0.000581	0.0042	CcSEcCtD
Captopril—Eosinophilia—Fluorouracil—colon cancer	0.000574	0.00415	CcSEcCtD
Captopril—Erectile dysfunction—Vincristine—colon cancer	0.000573	0.00414	CcSEcCtD
Captopril—Photosensitivity reaction—Vincristine—colon cancer	0.000567	0.0041	CcSEcCtD
Captopril—Neutropenia—Irinotecan—colon cancer	0.000566	0.00409	CcSEcCtD
Captopril—Angina pectoris—Fluorouracil—colon cancer	0.000565	0.00408	CcSEcCtD
Captopril—Weight decreased—Vincristine—colon cancer	0.000562	0.00407	CcSEcCtD
Captopril—Pancytopenia—Fluorouracil—colon cancer	0.000551	0.00398	CcSEcCtD
Captopril—Weight decreased—Irinotecan—colon cancer	0.000548	0.00396	CcSEcCtD
Captopril—Proteinuria—Methotrexate—colon cancer	0.000547	0.00396	CcSEcCtD
Captopril—Stomatitis—Vincristine—colon cancer	0.00054	0.00391	CcSEcCtD
Captopril—Protein urine present—Methotrexate—colon cancer	0.00054	0.0039	CcSEcCtD
Captopril—Diabetes mellitus—Capecitabine—colon cancer	0.000539	0.0039	CcSEcCtD
Captopril—Enalapril—ABCB1—colon cancer	0.000536	1	CrCbGaD
Captopril—Photosensitivity—Capecitabine—colon cancer	0.000534	0.00386	CcSEcCtD
Captopril—Polyuria—Capecitabine—colon cancer	0.000534	0.00386	CcSEcCtD
Captopril—Renal failure—Irinotecan—colon cancer	0.000531	0.00384	CcSEcCtD
Captopril—Photosensitivity reaction—Fluorouracil—colon cancer	0.000529	0.00383	CcSEcCtD
Captopril—Jaundice—Irinotecan—colon cancer	0.000526	0.0038	CcSEcCtD
Captopril—Stomatitis—Irinotecan—colon cancer	0.000526	0.0038	CcSEcCtD
Captopril—Glossitis—Methotrexate—colon cancer	0.000522	0.00377	CcSEcCtD
Captopril—Oliguria—Methotrexate—colon cancer	0.000522	0.00377	CcSEcCtD
Captopril—Haemolytic anaemia—Capecitabine—colon cancer	0.000519	0.00375	CcSEcCtD
Captopril—Ulcer—Methotrexate—colon cancer	0.000508	0.00367	CcSEcCtD
Captopril—Renal failure acute—Capecitabine—colon cancer	0.000508	0.00367	CcSEcCtD
Captopril—ALB—liver—colon cancer	0.000505	0.00287	CbGeAlD
Captopril—Stomatitis—Fluorouracil—colon cancer	0.000504	0.00364	CcSEcCtD
Captopril—Dermatitis exfoliative—Capecitabine—colon cancer	0.000497	0.00359	CcSEcCtD
Captopril—Hallucination—Vincristine—colon cancer	0.000495	0.00358	CcSEcCtD
Captopril—Vasculitis—Methotrexate—colon cancer	0.000493	0.00356	CcSEcCtD
Captopril—Dermatitis bullous—Capecitabine—colon cancer	0.000491	0.00355	CcSEcCtD
Captopril—Rhinitis—Irinotecan—colon cancer	0.000486	0.00351	CcSEcCtD
Captopril—ACE—liver—colon cancer	0.000483	0.00275	CbGeAlD
Captopril—Agranulocytosis—Fluorouracil—colon cancer	0.000482	0.00349	CcSEcCtD
Captopril—Cerebrovascular accident—Capecitabine—colon cancer	0.000478	0.00346	CcSEcCtD
Captopril—Hyponatraemia—Capecitabine—colon cancer	0.000471	0.0034	CcSEcCtD
Captopril—Rhinitis—Fluorouracil—colon cancer	0.000465	0.00336	CcSEcCtD
Captopril—Pharyngitis—Fluorouracil—colon cancer	0.000461	0.00333	CcSEcCtD
Captopril—Flushing—Irinotecan—colon cancer	0.00045	0.00325	CcSEcCtD
Captopril—Cardiac arrest—Capecitabine—colon cancer	0.000446	0.00322	CcSEcCtD
Captopril—Ataxia—Capecitabine—colon cancer	0.000441	0.00319	CcSEcCtD
Captopril—Alopecia—Vincristine—colon cancer	0.00044	0.00318	CcSEcCtD
Captopril—Urine output increased—Methotrexate—colon cancer	0.000435	0.00314	CcSEcCtD
Captopril—Gynaecomastia—Methotrexate—colon cancer	0.00043	0.00311	CcSEcCtD
Captopril—Alopecia—Irinotecan—colon cancer	0.000428	0.0031	CcSEcCtD
Captopril—Orthostatic hypotension—Capecitabine—colon cancer	0.000428	0.0031	CcSEcCtD
Captopril—Muscular weakness—Capecitabine—colon cancer	0.000413	0.00299	CcSEcCtD
Captopril—Alopecia—Fluorouracil—colon cancer	0.00041	0.00296	CcSEcCtD
Captopril—Lymphadenopathy—Methotrexate—colon cancer	0.000409	0.00296	CcSEcCtD
Captopril—Diabetes mellitus—Methotrexate—colon cancer	0.000401	0.0029	CcSEcCtD
Captopril—Anaemia—Vincristine—colon cancer	0.0004	0.00289	CcSEcCtD
Captopril—Bronchospasm—Capecitabine—colon cancer	0.000399	0.00288	CcSEcCtD
Captopril—Polyuria—Methotrexate—colon cancer	0.000397	0.00287	CcSEcCtD
Captopril—Photosensitivity—Methotrexate—colon cancer	0.000397	0.00287	CcSEcCtD
Captopril—Angina pectoris—Capecitabine—colon cancer	0.000395	0.00285	CcSEcCtD
Captopril—Ill-defined disorder—Irinotecan—colon cancer	0.000391	0.00283	CcSEcCtD
Captopril—Anaemia—Irinotecan—colon cancer	0.00039	0.00282	CcSEcCtD
Captopril—ALB—lymph node—colon cancer	0.000387	0.0022	CbGeAlD
Captopril—CYP2D6—renal system—colon cancer	0.000387	0.0022	CbGeAlD
Captopril—Pancytopenia—Capecitabine—colon cancer	0.000385	0.00278	CcSEcCtD
Captopril—Vision blurred—Fluorouracil—colon cancer	0.000381	0.00275	CcSEcCtD
Captopril—Malaise—Irinotecan—colon cancer	0.00038	0.00275	CcSEcCtD
Captopril—Neutropenia—Capecitabine—colon cancer	0.000379	0.00274	CcSEcCtD
Captopril—Syncope—Irinotecan—colon cancer	0.000378	0.00273	CcSEcCtD
Captopril—Renal failure acute—Methotrexate—colon cancer	0.000378	0.00273	CcSEcCtD
Captopril—Anaemia—Fluorouracil—colon cancer	0.000373	0.0027	CcSEcCtD
Captopril—Loss of consciousness—Irinotecan—colon cancer	0.000371	0.00268	CcSEcCtD
Captopril—ACE—lymph node—colon cancer	0.00037	0.00211	CbGeAlD
Captopril—Dermatitis exfoliative—Methotrexate—colon cancer	0.00037	0.00267	CcSEcCtD
Captopril—Photosensitivity reaction—Capecitabine—colon cancer	0.00037	0.00267	CcSEcCtD
Captopril—Myalgia—Vincristine—colon cancer	0.000369	0.00267	CcSEcCtD
Captopril—Cough—Irinotecan—colon cancer	0.000368	0.00266	CcSEcCtD
Captopril—ABCB1—embryo—colon cancer	0.000368	0.00209	CbGeAlD
Captopril—Weight decreased—Capecitabine—colon cancer	0.000367	0.00265	CcSEcCtD
Captopril—Anaphylactoid reaction—Methotrexate—colon cancer	0.000361	0.00261	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000358	0.00259	CcSEcCtD
Captopril—Cerebrovascular accident—Methotrexate—colon cancer	0.000356	0.00257	CcSEcCtD
Captopril—Renal failure—Capecitabine—colon cancer	0.000355	0.00257	CcSEcCtD
Captopril—Discomfort—Irinotecan—colon cancer	0.000355	0.00257	CcSEcCtD
Captopril—Anaphylactic shock—Vincristine—colon cancer	0.000353	0.00256	CcSEcCtD
Captopril—Stomatitis—Capecitabine—colon cancer	0.000352	0.00255	CcSEcCtD
Captopril—Jaundice—Capecitabine—colon cancer	0.000352	0.00255	CcSEcCtD
Captopril—Confusional state—Irinotecan—colon cancer	0.000347	0.00251	CcSEcCtD
Captopril—Thrombocytopenia—Vincristine—colon cancer	0.000346	0.0025	CcSEcCtD
Captopril—Anaphylactic shock—Irinotecan—colon cancer	0.000344	0.00249	CcSEcCtD
Captopril—Chest pain—Fluorouracil—colon cancer	0.000344	0.00249	CcSEcCtD
Captopril—Myalgia—Fluorouracil—colon cancer	0.000344	0.00249	CcSEcCtD
Captopril—Discomfort—Fluorouracil—colon cancer	0.00034	0.00246	CcSEcCtD
Captopril—Shock—Irinotecan—colon cancer	0.000339	0.00245	CcSEcCtD
Captopril—Agranulocytosis—Capecitabine—colon cancer	0.000337	0.00244	CcSEcCtD
Captopril—Thrombocytopenia—Irinotecan—colon cancer	0.000337	0.00244	CcSEcCtD
Captopril—Anorexia—Vincristine—colon cancer	0.000337	0.00244	CcSEcCtD
Captopril—Confusional state—Fluorouracil—colon cancer	0.000332	0.0024	CcSEcCtD
Captopril—Hypotension—Vincristine—colon cancer	0.00033	0.00239	CcSEcCtD
Captopril—Anaphylactic shock—Fluorouracil—colon cancer	0.00033	0.00238	CcSEcCtD
Captopril—Anorexia—Irinotecan—colon cancer	0.000328	0.00237	CcSEcCtD
Captopril—Ataxia—Methotrexate—colon cancer	0.000328	0.00237	CcSEcCtD
Captopril—Rhinitis—Capecitabine—colon cancer	0.000325	0.00235	CcSEcCtD
Captopril—Hepatitis—Capecitabine—colon cancer	0.000324	0.00234	CcSEcCtD
Captopril—Thrombocytopenia—Fluorouracil—colon cancer	0.000323	0.00233	CcSEcCtD
Captopril—Musculoskeletal discomfort—Vincristine—colon cancer	0.000322	0.00233	CcSEcCtD
Captopril—Pharyngitis—Capecitabine—colon cancer	0.000322	0.00233	CcSEcCtD
Captopril—Tachycardia—Fluorouracil—colon cancer	0.000322	0.00233	CcSEcCtD
Captopril—Hypotension—Irinotecan—colon cancer	0.000322	0.00233	CcSEcCtD
Captopril—Insomnia—Vincristine—colon cancer	0.00032	0.00231	CcSEcCtD
Captopril—Paraesthesia—Vincristine—colon cancer	0.000317	0.00229	CcSEcCtD
Captopril—CYP2D6—digestive system—colon cancer	0.000317	0.00181	CbGeAlD
Captopril—Anorexia—Fluorouracil—colon cancer	0.000314	0.00227	CcSEcCtD
Captopril—Insomnia—Irinotecan—colon cancer	0.000311	0.00225	CcSEcCtD
Captopril—Paraesthesia—Irinotecan—colon cancer	0.000309	0.00223	CcSEcCtD
Captopril—Hypotension—Fluorouracil—colon cancer	0.000308	0.00223	CcSEcCtD
Captopril—Decreased appetite—Vincristine—colon cancer	0.000307	0.00222	CcSEcCtD
Captopril—Dyspnoea—Irinotecan—colon cancer	0.000307	0.00222	CcSEcCtD
Captopril—Erythema multiforme—Capecitabine—colon cancer	0.000307	0.00222	CcSEcCtD
Captopril—Somnolence—Irinotecan—colon cancer	0.000306	0.00221	CcSEcCtD
Captopril—Fatigue—Vincristine—colon cancer	0.000305	0.0022	CcSEcCtD
Captopril—Dyspepsia—Irinotecan—colon cancer	0.000303	0.00219	CcSEcCtD
Captopril—Constipation—Vincristine—colon cancer	0.000302	0.00219	CcSEcCtD
Captopril—Flushing—Capecitabine—colon cancer	0.000301	0.00218	CcSEcCtD
Captopril—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.0003	0.00217	CcSEcCtD
Captopril—ABCB1—epithelium—colon cancer	0.0003	0.00171	CbGeAlD
Captopril—Decreased appetite—Irinotecan—colon cancer	0.000299	0.00216	CcSEcCtD
Captopril—Eosinophilia—Methotrexate—colon cancer	0.000299	0.00216	CcSEcCtD
Captopril—Insomnia—Fluorouracil—colon cancer	0.000298	0.00216	CcSEcCtD
Captopril—Fatigue—Irinotecan—colon cancer	0.000297	0.00215	CcSEcCtD
Captopril—Paraesthesia—Fluorouracil—colon cancer	0.000296	0.00214	CcSEcCtD
Captopril—Pancreatitis—Methotrexate—colon cancer	0.000296	0.00214	CcSEcCtD
Captopril—Constipation—Irinotecan—colon cancer	0.000294	0.00213	CcSEcCtD
Captopril—Dyspnoea—Fluorouracil—colon cancer	0.000294	0.00213	CcSEcCtD
Captopril—Somnolence—Fluorouracil—colon cancer	0.000293	0.00212	CcSEcCtD
Captopril—Dyspepsia—Fluorouracil—colon cancer	0.00029	0.0021	CcSEcCtD
Captopril—Gastrointestinal pain—Vincristine—colon cancer	0.000289	0.00209	CcSEcCtD
Captopril—Decreased appetite—Fluorouracil—colon cancer	0.000287	0.00207	CcSEcCtD
Captopril—Alopecia—Capecitabine—colon cancer	0.000287	0.00207	CcSEcCtD
Captopril—Pancytopenia—Methotrexate—colon cancer	0.000286	0.00207	CcSEcCtD
Captopril—Feeling abnormal—Irinotecan—colon cancer	0.000284	0.00205	CcSEcCtD
Captopril—Neutropenia—Methotrexate—colon cancer	0.000282	0.00204	CcSEcCtD
Captopril—Gastrointestinal pain—Irinotecan—colon cancer	0.000282	0.00204	CcSEcCtD
Captopril—Abdominal pain—Vincristine—colon cancer	0.000279	0.00202	CcSEcCtD
Captopril—Body temperature increased—Vincristine—colon cancer	0.000279	0.00202	CcSEcCtD
Captopril—ABCB1—renal system—colon cancer	0.000278	0.00158	CbGeAlD
Captopril—Erectile dysfunction—Methotrexate—colon cancer	0.000278	0.00201	CcSEcCtD
Captopril—Dysgeusia—Capecitabine—colon cancer	0.000276	0.002	CcSEcCtD
Captopril—Photosensitivity reaction—Methotrexate—colon cancer	0.000275	0.00199	CcSEcCtD
Captopril—Body temperature increased—Irinotecan—colon cancer	0.000272	0.00197	CcSEcCtD
Captopril—Abdominal pain—Irinotecan—colon cancer	0.000272	0.00197	CcSEcCtD
Captopril—Feeling abnormal—Fluorouracil—colon cancer	0.000272	0.00196	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000267	0.00193	CcSEcCtD
Captopril—Vision blurred—Capecitabine—colon cancer	0.000266	0.00192	CcSEcCtD
Captopril—Renal failure—Methotrexate—colon cancer	0.000264	0.00191	CcSEcCtD
Captopril—Stomatitis—Methotrexate—colon cancer	0.000262	0.0019	CcSEcCtD
Captopril—Ill-defined disorder—Capecitabine—colon cancer	0.000262	0.00189	CcSEcCtD
Captopril—Anaemia—Capecitabine—colon cancer	0.000261	0.00189	CcSEcCtD
Captopril—Body temperature increased—Fluorouracil—colon cancer	0.000261	0.00188	CcSEcCtD
Captopril—Malaise—Capecitabine—colon cancer	0.000255	0.00184	CcSEcCtD
Captopril—Asthenia—Vincristine—colon cancer	0.000254	0.00183	CcSEcCtD
Captopril—Syncope—Capecitabine—colon cancer	0.000253	0.00183	CcSEcCtD
Captopril—Agranulocytosis—Methotrexate—colon cancer	0.000251	0.00181	CcSEcCtD
Captopril—Palpitations—Capecitabine—colon cancer	0.000249	0.0018	CcSEcCtD
Captopril—Loss of consciousness—Capecitabine—colon cancer	0.000248	0.00179	CcSEcCtD
Captopril—Asthenia—Irinotecan—colon cancer	0.000247	0.00179	CcSEcCtD
Captopril—Cough—Capecitabine—colon cancer	0.000246	0.00178	CcSEcCtD
Captopril—Diarrhoea—Vincristine—colon cancer	0.000242	0.00175	CcSEcCtD
Captopril—Hepatitis—Methotrexate—colon cancer	0.000241	0.00175	CcSEcCtD
Captopril—Chest pain—Capecitabine—colon cancer	0.00024	0.00174	CcSEcCtD
Captopril—Myalgia—Capecitabine—colon cancer	0.00024	0.00174	CcSEcCtD
Captopril—Arthralgia—Capecitabine—colon cancer	0.00024	0.00174	CcSEcCtD
Captopril—Pharyngitis—Methotrexate—colon cancer	0.00024	0.00173	CcSEcCtD
Captopril—Discomfort—Capecitabine—colon cancer	0.000237	0.00172	CcSEcCtD
Captopril—CYP2D6—liver—colon cancer	0.000236	0.00135	CbGeAlD
Captopril—Diarrhoea—Irinotecan—colon cancer	0.000236	0.0017	CcSEcCtD
Captopril—Dry mouth—Capecitabine—colon cancer	0.000235	0.0017	CcSEcCtD
Captopril—Dizziness—Vincristine—colon cancer	0.000234	0.00169	CcSEcCtD
Captopril—Pruritus—Fluorouracil—colon cancer	0.000233	0.00169	CcSEcCtD
Captopril—Confusional state—Capecitabine—colon cancer	0.000232	0.00168	CcSEcCtD
Captopril—ABCB1—lymphoid tissue—colon cancer	0.000231	0.00132	CbGeAlD
Captopril—Erythema multiforme—Methotrexate—colon cancer	0.000228	0.00165	CcSEcCtD
Captopril—ABCB1—digestive system—colon cancer	0.000228	0.0013	CbGeAlD
Captopril—Dizziness—Irinotecan—colon cancer	0.000228	0.00165	CcSEcCtD
Captopril—Shock—Capecitabine—colon cancer	0.000227	0.00164	CcSEcCtD
Captopril—Diarrhoea—Fluorouracil—colon cancer	0.000226	0.00163	CcSEcCtD
Captopril—Thrombocytopenia—Capecitabine—colon cancer	0.000226	0.00163	CcSEcCtD
Captopril—Tachycardia—Capecitabine—colon cancer	0.000225	0.00163	CcSEcCtD
Captopril—Vomiting—Vincristine—colon cancer	0.000225	0.00162	CcSEcCtD
Captopril—Rash—Vincristine—colon cancer	0.000223	0.00161	CcSEcCtD
Captopril—Dermatitis—Vincristine—colon cancer	0.000223	0.00161	CcSEcCtD
Captopril—Headache—Vincristine—colon cancer	0.000221	0.0016	CcSEcCtD
Captopril—Anorexia—Capecitabine—colon cancer	0.00022	0.00159	CcSEcCtD
Captopril—Vomiting—Irinotecan—colon cancer	0.000219	0.00158	CcSEcCtD
Captopril—Dizziness—Fluorouracil—colon cancer	0.000218	0.00158	CcSEcCtD
Captopril—Rash—Irinotecan—colon cancer	0.000217	0.00157	CcSEcCtD
Captopril—Dermatitis—Irinotecan—colon cancer	0.000217	0.00157	CcSEcCtD
Captopril—Headache—Irinotecan—colon cancer	0.000216	0.00156	CcSEcCtD
Captopril—Hypotension—Capecitabine—colon cancer	0.000215	0.00156	CcSEcCtD
Captopril—Alopecia—Methotrexate—colon cancer	0.000213	0.00154	CcSEcCtD
Captopril—ABCB1—bone marrow—colon cancer	0.00021	0.0012	CbGeAlD
Captopril—Nausea—Vincristine—colon cancer	0.00021	0.00152	CcSEcCtD
Captopril—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00021	0.00152	CcSEcCtD
Captopril—Vomiting—Fluorouracil—colon cancer	0.00021	0.00152	CcSEcCtD
Captopril—Insomnia—Capecitabine—colon cancer	0.000208	0.00151	CcSEcCtD
Captopril—Rash—Fluorouracil—colon cancer	0.000208	0.0015	CcSEcCtD
Captopril—Dermatitis—Fluorouracil—colon cancer	0.000208	0.0015	CcSEcCtD
Captopril—Paraesthesia—Capecitabine—colon cancer	0.000207	0.0015	CcSEcCtD
Captopril—Headache—Fluorouracil—colon cancer	0.000207	0.00149	CcSEcCtD
Captopril—Dysgeusia—Methotrexate—colon cancer	0.000206	0.00149	CcSEcCtD
Captopril—Dyspnoea—Capecitabine—colon cancer	0.000205	0.00149	CcSEcCtD
Captopril—Nausea—Irinotecan—colon cancer	0.000204	0.00148	CcSEcCtD
Captopril—Dyspepsia—Capecitabine—colon cancer	0.000203	0.00147	CcSEcCtD
Captopril—ABCB1—vagina—colon cancer	0.000202	0.00115	CbGeAlD
Captopril—Decreased appetite—Capecitabine—colon cancer	0.0002	0.00145	CcSEcCtD
Captopril—Fatigue—Capecitabine—colon cancer	0.000199	0.00144	CcSEcCtD
Captopril—Vision blurred—Methotrexate—colon cancer	0.000198	0.00143	CcSEcCtD
Captopril—Constipation—Capecitabine—colon cancer	0.000197	0.00142	CcSEcCtD
Captopril—Nausea—Fluorouracil—colon cancer	0.000196	0.00142	CcSEcCtD
Captopril—Ill-defined disorder—Methotrexate—colon cancer	0.000195	0.00141	CcSEcCtD
Captopril—Anaemia—Methotrexate—colon cancer	0.000194	0.0014	CcSEcCtD
Captopril—F2—Regulation of Actin Cytoskeleton—FGFR3—colon cancer	0.000193	0.00185	CbGpPWpGaD
Captopril—Feeling abnormal—Capecitabine—colon cancer	0.00019	0.00137	CcSEcCtD
Captopril—Malaise—Methotrexate—colon cancer	0.00019	0.00137	CcSEcCtD
Captopril—MMP9—AP-1 transcription factor network—TP53—colon cancer	0.000189	0.00182	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—CCND1—colon cancer	0.000189	0.00182	CbGpPWpGaD
Captopril—Gastrointestinal pain—Capecitabine—colon cancer	0.000188	0.00136	CcSEcCtD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—EP300—colon cancer	0.000183	0.00176	CbGpPWpGaD
Captopril—Cough—Methotrexate—colon cancer	0.000183	0.00133	CcSEcCtD
Captopril—Body temperature increased—Capecitabine—colon cancer	0.000182	0.00132	CcSEcCtD
Captopril—Abdominal pain—Capecitabine—colon cancer	0.000182	0.00132	CcSEcCtD
Captopril—F2—Metabolism of proteins—CDX2—colon cancer	0.000181	0.00173	CbGpPWpGaD
Captopril—LTA4H—Metabolism—ABCB1—colon cancer	0.000179	0.00172	CbGpPWpGaD
Captopril—F2—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	0.000179	0.00172	CbGpPWpGaD
Captopril—Myalgia—Methotrexate—colon cancer	0.000179	0.00129	CcSEcCtD
Captopril—Chest pain—Methotrexate—colon cancer	0.000179	0.00129	CcSEcCtD
Captopril—Arthralgia—Methotrexate—colon cancer	0.000179	0.00129	CcSEcCtD
Captopril—F2—Regulation of Actin Cytoskeleton—APC—colon cancer	0.000177	0.0017	CbGpPWpGaD
Captopril—Discomfort—Methotrexate—colon cancer	0.000177	0.00128	CcSEcCtD
Captopril—LTA4H—Metabolism—TYMS—colon cancer	0.000176	0.00169	CbGpPWpGaD
Captopril—Confusional state—Methotrexate—colon cancer	0.000173	0.00125	CcSEcCtD
Captopril—MMP9—Validated targets of C-MYC transcriptional activation—TP53—colon cancer	0.000172	0.00165	CbGpPWpGaD
Captopril—MMP9—Endochondral Ossification—AKT1—colon cancer	0.000172	0.00165	CbGpPWpGaD
Captopril—MMP9—LPA receptor mediated events—AKT1—colon cancer	0.000172	0.00165	CbGpPWpGaD
Captopril—Anaphylactic shock—Methotrexate—colon cancer	0.000172	0.00124	CcSEcCtD
Captopril—ABCB1—liver—colon cancer	0.00017	0.000968	CbGeAlD
Captopril—MMP9—CXCR4-mediated signaling events—PIK3CA—colon cancer	0.000169	0.00163	CbGpPWpGaD
Captopril—Thrombocytopenia—Methotrexate—colon cancer	0.000168	0.00121	CcSEcCtD
Captopril—MMP9—AGE/RAGE pathway—AKT1—colon cancer	0.000168	0.00161	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—BRAF—colon cancer	0.000166	0.0016	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—TP53—colon cancer	0.000166	0.00159	CbGpPWpGaD
Captopril—Asthenia—Capecitabine—colon cancer	0.000165	0.0012	CcSEcCtD
Captopril—Anorexia—Methotrexate—colon cancer	0.000163	0.00118	CcSEcCtD
Captopril—MMP9—Signaling Pathways—DLC1—colon cancer	0.000163	0.00157	CbGpPWpGaD
Captopril—Pruritus—Capecitabine—colon cancer	0.000163	0.00118	CcSEcCtD
Captopril—F2—Angiopoietin receptor Tie2-mediated signaling—AKT1—colon cancer	0.000162	0.00155	CbGpPWpGaD
Captopril—Hypotension—Methotrexate—colon cancer	0.00016	0.00116	CcSEcCtD
Captopril—MMP9—Signaling by SCF-KIT—CDKN1A—colon cancer	0.000159	0.00153	CbGpPWpGaD
Captopril—Diarrhoea—Capecitabine—colon cancer	0.000158	0.00114	CcSEcCtD
Captopril—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000156	0.00113	CcSEcCtD
Captopril—MMP2—Extracellular matrix organization—CASP3—colon cancer	0.000156	0.0015	CbGpPWpGaD
Captopril—Insomnia—Methotrexate—colon cancer	0.000155	0.00112	CcSEcCtD
Captopril—Paraesthesia—Methotrexate—colon cancer	0.000154	0.00111	CcSEcCtD
Captopril—F2—Metabolism of proteins—MUC2—colon cancer	0.000153	0.00147	CbGpPWpGaD
Captopril—F2—Folate Metabolism—TP53—colon cancer	0.000153	0.00147	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—LGR5—colon cancer	0.000153	0.00147	CbGpPWpGaD
Captopril—Dyspnoea—Methotrexate—colon cancer	0.000153	0.00111	CcSEcCtD
Captopril—Somnolence—Methotrexate—colon cancer	0.000152	0.0011	CcSEcCtD
Captopril—Dizziness—Capecitabine—colon cancer	0.000152	0.0011	CcSEcCtD
Captopril—MMP9—Spinal Cord Injury—MYC—colon cancer	0.000152	0.00146	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—TGFB1—colon cancer	0.000152	0.00146	CbGpPWpGaD
Captopril—Dyspepsia—Methotrexate—colon cancer	0.000151	0.00109	CcSEcCtD
Captopril—F2—Cell surface interactions at the vascular wall—SRC—colon cancer	0.000151	0.00145	CbGpPWpGaD
Captopril—Decreased appetite—Methotrexate—colon cancer	0.000149	0.00108	CcSEcCtD
Captopril—MMP9—Spinal Cord Injury—EGFR—colon cancer	0.000149	0.00143	CbGpPWpGaD
Captopril—Fatigue—Methotrexate—colon cancer	0.000148	0.00107	CcSEcCtD
Captopril—MMP9—Signaling by SCF-KIT—SRC—colon cancer	0.000147	0.00141	CbGpPWpGaD
Captopril—Vomiting—Capecitabine—colon cancer	0.000146	0.00106	CcSEcCtD
Captopril—Rash—Capecitabine—colon cancer	0.000145	0.00105	CcSEcCtD
Captopril—Dermatitis—Capecitabine—colon cancer	0.000145	0.00105	CcSEcCtD
Captopril—F2—Cell surface interactions at the vascular wall—NRAS—colon cancer	0.000145	0.00139	CbGpPWpGaD
Captopril—Headache—Capecitabine—colon cancer	0.000144	0.00104	CcSEcCtD
Captopril—MMP9—EPH-Ephrin signaling—HRAS—colon cancer	0.000143	0.00138	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—NRAS—colon cancer	0.000141	0.00136	CbGpPWpGaD
Captopril—Feeling abnormal—Methotrexate—colon cancer	0.000141	0.00102	CcSEcCtD
Captopril—REN—Metabolism of proteins—CTNNB1—colon cancer	0.000141	0.00136	CbGpPWpGaD
Captopril—Gastrointestinal pain—Methotrexate—colon cancer	0.00014	0.00101	CcSEcCtD
Captopril—MMP9—CXCR4-mediated signaling events—AKT1—colon cancer	0.000138	0.00133	CbGpPWpGaD
Captopril—Nausea—Capecitabine—colon cancer	0.000137	0.000989	CcSEcCtD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	0.000136	0.0013	CbGpPWpGaD
Captopril—Abdominal pain—Methotrexate—colon cancer	0.000136	0.00098	CcSEcCtD
Captopril—Body temperature increased—Methotrexate—colon cancer	0.000136	0.00098	CcSEcCtD
Captopril—MMP9—Extracellular matrix organization—CDH1—colon cancer	0.000133	0.00128	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.000133	0.00128	CbGpPWpGaD
Captopril—ABCB1—lymph node—colon cancer	0.00013	0.000742	CbGeAlD
Captopril—MMP2—Developmental Biology—PPARG—colon cancer	0.000129	0.00124	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—EGFR—colon cancer	0.000129	0.00124	CbGpPWpGaD
Captopril—F2—Signaling Pathways—DLC1—colon cancer	0.000126	0.00121	CbGpPWpGaD
Captopril—LTA4H—Metabolism—PPARG—colon cancer	0.000125	0.0012	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—TP53—colon cancer	0.000125	0.0012	CbGpPWpGaD
Captopril—F2—Cell surface interactions at the vascular wall—KRAS—colon cancer	0.000125	0.0012	CbGpPWpGaD
Captopril—Asthenia—Methotrexate—colon cancer	0.000123	0.00089	CcSEcCtD
Captopril—MMP9—Signaling by SCF-KIT—KRAS—colon cancer	0.000122	0.00117	CbGpPWpGaD
Captopril—Pruritus—Methotrexate—colon cancer	0.000121	0.000877	CcSEcCtD
Captopril—MMP2—Extracellular matrix organization—TGFB1—colon cancer	0.000121	0.00117	CbGpPWpGaD
Captopril—F2—Signaling Pathways—LGR5—colon cancer	0.000118	0.00114	CbGpPWpGaD
Captopril—Diarrhoea—Methotrexate—colon cancer	0.000117	0.000848	CcSEcCtD
Captopril—MMP2—Axon guidance—SRC—colon cancer	0.000115	0.00111	CbGpPWpGaD
Captopril—F2—Cell surface interactions at the vascular wall—PIK3CA—colon cancer	0.000115	0.0011	CbGpPWpGaD
Captopril—Dizziness—Methotrexate—colon cancer	0.000113	0.00082	CcSEcCtD
Captopril—MMP2—Axon guidance—VEGFA—colon cancer	0.000112	0.00108	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.000112	0.00108	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—PIK3CA—colon cancer	0.000112	0.00107	CbGpPWpGaD
Captopril—MMP2—Axon guidance—NRAS—colon cancer	0.000111	0.00106	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AXIN2—colon cancer	0.00011	0.00106	CbGpPWpGaD
Captopril—Vomiting—Methotrexate—colon cancer	0.000109	0.000788	CcSEcCtD
Captopril—Rash—Methotrexate—colon cancer	0.000108	0.000782	CcSEcCtD
Captopril—Dermatitis—Methotrexate—colon cancer	0.000108	0.000781	CcSEcCtD
Captopril—Headache—Methotrexate—colon cancer	0.000107	0.000777	CcSEcCtD
Captopril—F2—Cell surface interactions at the vascular wall—HRAS—colon cancer	0.000106	0.00102	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—NRAS—colon cancer	0.000105	0.001	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—HRAS—colon cancer	0.000103	0.000994	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—CASP3—colon cancer	0.000102	0.000982	CbGpPWpGaD
Captopril—Nausea—Methotrexate—colon cancer	0.000102	0.000737	CcSEcCtD
Captopril—MMP2—Axon guidance—EGFR—colon cancer	0.000101	0.00097	CbGpPWpGaD
Captopril—LTA4H—Metabolism—PTGS2—colon cancer	9.82e-05	0.000944	CbGpPWpGaD
Captopril—MMP2—Axon guidance—KRAS—colon cancer	9.54e-05	0.000917	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—EGFR—colon cancer	9.52e-05	0.000915	CbGpPWpGaD
Captopril—ALB—Metabolism—CA7—colon cancer	9.27e-05	0.000891	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—AKT1—colon cancer	9.14e-05	0.000878	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—CTNNB1—colon cancer	9.1e-05	0.000874	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—KRAS—colon cancer	8.99e-05	0.000864	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	8.96e-05	0.000861	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AXIN2—colon cancer	8.51e-05	0.000817	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—PPARG—colon cancer	8.48e-05	0.000814	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—EP300—colon cancer	8.46e-05	0.000812	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—PIK3CA—colon cancer	8.26e-05	0.000794	CbGpPWpGaD
Captopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	8.24e-05	0.000792	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—SRC—colon cancer	8.22e-05	0.00079	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—ABCB1—colon cancer	8.22e-05	0.000789	CbGpPWpGaD
Captopril—LTA4H—Metabolism—EP300—colon cancer	8.17e-05	0.000785	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CA7—colon cancer	8.13e-05	0.000781	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—PTGS2—colon cancer	8.12e-05	0.00078	CbGpPWpGaD
Captopril—MMP2—Axon guidance—HRAS—colon cancer	8.11e-05	0.000779	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—VEGFA—colon cancer	8.01e-05	0.000769	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—TGFB1—colon cancer	7.96e-05	0.000765	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—SRC—colon cancer	7.92e-05	0.000761	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—NRAS—colon cancer	7.91e-05	0.00076	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—colon cancer	7.79e-05	0.000749	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—VEGFA—colon cancer	7.72e-05	0.000742	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CA7—colon cancer	7.66e-05	0.000736	CbGpPWpGaD
Captopril—MMP9—Axon guidance—SRC—colon cancer	7.56e-05	0.000726	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	7.45e-05	0.000716	CbGpPWpGaD
Captopril—MMP9—Axon guidance—VEGFA—colon cancer	7.36e-05	0.000707	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—TGFB1—colon cancer	7.35e-05	0.000706	CbGpPWpGaD
Captopril—MMP9—Axon guidance—NRAS—colon cancer	7.27e-05	0.000699	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—EGFR—colon cancer	7.21e-05	0.000692	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—CASP3—colon cancer	7.2e-05	0.000692	CbGpPWpGaD
Captopril—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	7.11e-05	0.000683	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—colon cancer	7.1e-05	0.000682	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—TGFB1—colon cancer	7.08e-05	0.000681	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	7.06e-05	0.000678	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—CTNNB1—colon cancer	7.02e-05	0.000674	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—VEGFA—colon cancer	6.9e-05	0.000663	CbGpPWpGaD
Captopril—F2—G alpha (q) signalling events—PIK3CA—colon cancer	6.89e-05	0.000662	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	6.87e-05	0.00066	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—KRAS—colon cancer	6.81e-05	0.000654	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—colon cancer	6.71e-05	0.000644	CbGpPWpGaD
Captopril—MMP9—Axon guidance—EGFR—colon cancer	6.62e-05	0.000636	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	6.62e-05	0.000636	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	6.58e-05	0.000632	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—TGFB1—colon cancer	6.34e-05	0.000609	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—CTNNB1—colon cancer	6.31e-05	0.000606	CbGpPWpGaD
Captopril—MMP9—Axon guidance—KRAS—colon cancer	6.26e-05	0.000601	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—colon cancer	6.16e-05	0.000592	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—VEGFA—colon cancer	6.11e-05	0.000587	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—ABCB1—colon cancer	6.1e-05	0.000586	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—TP53—colon cancer	6.09e-05	0.000585	CbGpPWpGaD
Captopril—LTA4H—Metabolism—PIK3CA—colon cancer	6.04e-05	0.000581	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	6.04e-05	0.00058	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	6.03e-05	0.000579	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—CTNNB1—colon cancer	5.97e-05	0.000573	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—HRAS—colon cancer	5.79e-05	0.000556	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—colon cancer	5.7e-05	0.000548	CbGpPWpGaD
Captopril—ALB—Metabolism—CHST5—colon cancer	5.62e-05	0.00054	CbGpPWpGaD
Captopril—ALB—Metabolism—ODC1—colon cancer	5.62e-05	0.00054	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—TGFB1—colon cancer	5.61e-05	0.000539	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—EP300—colon cancer	5.55e-05	0.000533	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—SRC—colon cancer	5.39e-05	0.000518	CbGpPWpGaD
Captopril—MMP9—Axon guidance—HRAS—colon cancer	5.32e-05	0.000511	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—VEGFA—colon cancer	5.25e-05	0.000505	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—NRAS—colon cancer	5.19e-05	0.000499	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—AKT1—colon cancer	5.11e-05	0.000491	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	5.04e-05	0.000484	CbGpPWpGaD
Captopril—LTA4H—Metabolism—AKT1—colon cancer	4.94e-05	0.000474	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—AKT1—colon cancer	4.92e-05	0.000473	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ODC1—colon cancer	4.92e-05	0.000473	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CHST5—colon cancer	4.92e-05	0.000473	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TGFB1—colon cancer	4.82e-05	0.000463	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—EGFR—colon cancer	4.73e-05	0.000454	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ODC1—colon cancer	4.64e-05	0.000446	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CHST5—colon cancer	4.64e-05	0.000446	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	4.5e-05	0.000433	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—KRAS—colon cancer	4.47e-05	0.000429	CbGpPWpGaD
Captopril—F2—Hemostasis—EP300—colon cancer	4.2e-05	0.000404	CbGpPWpGaD
Captopril—F2—Hemostasis—SRC—colon cancer	4.08e-05	0.000392	CbGpPWpGaD
Captopril—F2—Hemostasis—VEGFA—colon cancer	3.98e-05	0.000382	CbGpPWpGaD
Captopril—F2—Hemostasis—NRAS—colon cancer	3.93e-05	0.000378	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	3.83e-05	0.000368	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—HRAS—colon cancer	3.8e-05	0.000365	CbGpPWpGaD
Captopril—F2—Hemostasis—TGFB1—colon cancer	3.65e-05	0.000351	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—CTNNB1—colon cancer	3.56e-05	0.000342	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	3.55e-05	0.000341	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	3.46e-05	0.000332	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	3.43e-05	0.000329	CbGpPWpGaD
Captopril—F2—Hemostasis—KRAS—colon cancer	3.38e-05	0.000325	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—AKT1—colon cancer	3.35e-05	0.000322	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	3.35e-05	0.000322	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	3.18e-05	0.000306	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FGFR3—colon cancer	3.18e-05	0.000306	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—ABCB1—colon cancer	3.17e-05	0.000305	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—SRC—colon cancer	3.14e-05	0.000302	CbGpPWpGaD
Captopril—F2—Hemostasis—PIK3CA—colon cancer	3.11e-05	0.000299	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	3.1e-05	0.000297	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—VEGFA—colon cancer	3.06e-05	0.000294	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	3.02e-05	0.00029	CbGpPWpGaD
Captopril—F2—Hemostasis—TP53—colon cancer	3.01e-05	0.000289	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—APC—colon cancer	2.92e-05	0.000281	CbGpPWpGaD
Captopril—F2—Hemostasis—HRAS—colon cancer	2.88e-05	0.000276	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—TGFB1—colon cancer	2.81e-05	0.00027	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	2.77e-05	0.000267	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	2.77e-05	0.000266	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—BRAF—colon cancer	2.75e-05	0.000264	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	2.71e-05	0.000261	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	2.56e-05	0.000246	CbGpPWpGaD
Captopril—F2—Hemostasis—AKT1—colon cancer	2.54e-05	0.000244	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FGFR3—colon cancer	2.46e-05	0.000236	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	2.39e-05	0.00023	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	2.36e-05	0.000226	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.32e-05	0.000223	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	2.28e-05	0.000219	CbGpPWpGaD
Captopril—F2—Signaling Pathways—APC—colon cancer	2.26e-05	0.000217	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—NRAS—colon cancer	2.26e-05	0.000217	CbGpPWpGaD
Captopril—F2—Signaling Pathways—BRAF—colon cancer	2.12e-05	0.000204	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CASP3—colon cancer	2.06e-05	0.000198	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—EGFR—colon cancer	2.05e-05	0.000197	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCND1—colon cancer	2e-05	0.000193	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CTNNB1—colon cancer	1.98e-05	0.000191	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—PIK3CA—colon cancer	1.96e-05	0.000189	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—AKT1—colon cancer	1.95e-05	0.000188	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—KRAS—colon cancer	1.94e-05	0.000186	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CDKN1A—colon cancer	1.94e-05	0.000186	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	1.92e-05	0.000185	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—EP300—colon cancer	1.84e-05	0.000177	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.82e-05	0.000175	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SRC—colon cancer	1.79e-05	0.000172	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PIK3CA—colon cancer	1.78e-05	0.000171	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—VEGFA—colon cancer	1.75e-05	0.000168	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NRAS—colon cancer	1.73e-05	0.000166	CbGpPWpGaD
Captopril—ALB—Hemostasis—EP300—colon cancer	1.67e-05	0.00016	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—HRAS—colon cancer	1.65e-05	0.000159	CbGpPWpGaD
Captopril—ALB—Hemostasis—SRC—colon cancer	1.62e-05	0.000156	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MYC—colon cancer	1.61e-05	0.000154	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—AKT1—colon cancer	1.6e-05	0.000154	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TGFB1—colon cancer	1.6e-05	0.000154	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CASP3—colon cancer	1.59e-05	0.000153	CbGpPWpGaD
Captopril—ALB—Hemostasis—VEGFA—colon cancer	1.58e-05	0.000152	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—EGFR—colon cancer	1.57e-05	0.000151	CbGpPWpGaD
Captopril—ALB—Hemostasis—NRAS—colon cancer	1.56e-05	0.00015	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCND1—colon cancer	1.55e-05	0.000149	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CTNNB1—colon cancer	1.53e-05	0.000147	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.52e-05	0.000146	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CDKN1A—colon cancer	1.5e-05	0.000144	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—KRAS—colon cancer	1.49e-05	0.000143	CbGpPWpGaD
Captopril—ALB—Metabolism—ABCB1—colon cancer	1.48e-05	0.000143	CbGpPWpGaD
Captopril—ALB—Metabolism—TYMS—colon cancer	1.46e-05	0.00014	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—AKT1—colon cancer	1.46e-05	0.00014	CbGpPWpGaD
Captopril—ALB—Hemostasis—TGFB1—colon cancer	1.45e-05	0.000139	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EP300—colon cancer	1.42e-05	0.000137	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SRC—colon cancer	1.38e-05	0.000133	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PIK3CA—colon cancer	1.36e-05	0.000131	CbGpPWpGaD
Captopril—F2—Signaling Pathways—VEGFA—colon cancer	1.35e-05	0.00013	CbGpPWpGaD
Captopril—ALB—Hemostasis—KRAS—colon cancer	1.34e-05	0.000129	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NRAS—colon cancer	1.33e-05	0.000128	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TP53—colon cancer	1.32e-05	0.000127	CbGpPWpGaD
Captopril—ABCB1—Metabolism—TYMS—colon cancer	1.28e-05	0.000123	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HRAS—colon cancer	1.26e-05	0.000121	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MYC—colon cancer	1.24e-05	0.000119	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TGFB1—colon cancer	1.24e-05	0.000119	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3CA—colon cancer	1.23e-05	0.000118	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ABCB1—colon cancer	1.23e-05	0.000118	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EGFR—colon cancer	1.21e-05	0.000117	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—TYMS—colon cancer	1.2e-05	0.000116	CbGpPWpGaD
Captopril—ALB—Hemostasis—TP53—colon cancer	1.19e-05	0.000115	CbGpPWpGaD
Captopril—F2—Signaling Pathways—KRAS—colon cancer	1.15e-05	0.00011	CbGpPWpGaD
Captopril—ALB—Hemostasis—HRAS—colon cancer	1.14e-05	0.00011	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.12e-05	0.000108	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AKT1—colon cancer	1.11e-05	0.000107	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3CA—colon cancer	1.05e-05	0.000101	CbGpPWpGaD
Captopril—ALB—Metabolism—PPARG—colon cancer	1.03e-05	9.92e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TP53—colon cancer	1.02e-05	9.79e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—AKT1—colon cancer	1.01e-05	9.68e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HRAS—colon cancer	9.75e-06	9.36e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PPARG—colon cancer	9.05e-06	8.7e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AKT1—colon cancer	8.61e-06	8.27e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PPARG—colon cancer	8.53e-06	8.19e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PTGS2—colon cancer	8.13e-06	7.81e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTGS2—colon cancer	7.12e-06	6.84e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—EP300—colon cancer	6.76e-06	6.49e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTGS2—colon cancer	6.71e-06	6.45e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—EP300—colon cancer	5.92e-06	5.69e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—EP300—colon cancer	5.58e-06	5.36e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3CA—colon cancer	5e-06	4.8e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3CA—colon cancer	4.38e-06	4.21e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3CA—colon cancer	4.13e-06	3.97e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—AKT1—colon cancer	4.08e-06	3.92e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—AKT1—colon cancer	3.58e-06	3.44e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—AKT1—colon cancer	3.37e-06	3.24e-05	CbGpPWpGaD
